a robust association between cannabis use, heavy use, and misuse with future risk of
schizophrenia. 1-3 Despite adjusting for covariates, including current psychotic symptoms …

Introduction: Chronic cannabis use is associated with neuroanatomical alterations in the
hippocampus. While adverse impacts of cannabis use are generally attributed to Δ9 …

Background: People with schizophrenia are more likely to develop cannabis use disorder
(CUD) and experience worse outcomes with use. Yet as cannabis is legalized for medical …

This article aims to evaluate “racial”, ethnic, and population diversity—or lack thereof—in
psychosis research, with a particular focus on socio-environmental studies. Samples of …

Background and Objectives Cannabis use is common in people with and mood and anxiety
disorders (ADs), and rates of problematic use are higher than in the general population …

This study aimed to systematically review and synthesise the available evidence on the
prevalence and associations between psychotic-like experiences (PLEs) and substance use …

With the proposed Canadian July 2018 legalization of marijuana through the Cannabis Act,
a thorough critical analysis of the current trials on the efficacy of medicinal marijuana (MM) …

In 2005 and 2008, studies reported that cannabis in England had become dominated by the
sinsemilla (unseeded female) form. The average potency (Δ9‐tetrahydrocannabinol [THC] …

Posttraumatic stress disorder (PTSD) is common in the general population, yet there are
limitations to the effectiveness, tolerability, and acceptability of available first‐line …

There has been a shift surrounding societal and legal perspectives on cannabis reflecting
changing public attitudes towards the perceived safety and social acceptability of cannabis …